Annie Tsong

Annie Tsong was appointed Chief Strategy and Product Officer in 2021 and is responsible for developing Amyris’ extensive pipeline of products and ingredients. She maintains the strategic portfolio by identifying the intersection between market needs and areas where Amyris’ technology offers new value.

A long-time Amyris veteran, Annie joined Amyris in 2008 in the Research and Development division, where she was central in establishing the company’s foundational microbial production platform. Subsequently, she established a Program Management Office which brought Amyris’ highest priority molecules to market by integrating activity across capabilities from upstream R&D to commercialization. Most recently, Annie turned her attention to Product Innovation, where her team established an ingredient development pipeline focused on fast-to-market opportunities that support Amyris’ strategic objectives. Annie has authored multiple landmark scientific publications in the fields of metabolic engineering and evolution of transcriptional regulation. She is an inventor on many key patents in Amyris’ IP portfolio, and a frequent speaker at international scientific conferences.

Annie holds an AB in Biochemical Sciences from Harvard University, a Ph.D. in genetics from University of California, San Francisco, and was a Miller Fellow at University of California, Berkeley.